A new exploratory agent has been tested in the treatment of the hepatitis C virus infection (HCV), allowing patients to avoid the current interferon treatment that comes with harsh side effects. The drug is sofosbuvir, an oral nucleotide inhibitor of the viral polymerase. MNT
0 comments:
Post a Comment